|
Mahooti, Sepi; Porter, Kyle; Alpaugh, Mary L et al. (2010) Breast carcinomatous tumoral emboli can result from encircling lymphovasculogenesis rather than lymphovascular invasion. Oncotarget 1:131-47
|
|
Barsky, Sanford H; Karlin, Nina J (2006) Mechanisms of disease: breast tumor pathogenesis and the role of the myoepithelial cell. Nat Clin Pract Oncol 3:138-51
|
|
Barsky, Sanford H; Karlin, Nina J (2005) Myoepithelial cells: autocrine and paracrine suppressors of breast cancer progression. J Mammary Gland Biol Neoplasia 10:249-60
|
|
Barsky, Sanford H (2003) Myoepithelial mRNA expression profiling reveals a common tumor-suppressor phenotype. Exp Mol Pathol 74:113-22
|
|
Shao, Z M; Radziszewski, W J; Barsky, S H (2000) Tamoxifen enhances myoepithelial cell suppression of human breast carcinoma progression in vitro by two different effector mechanisms. Cancer Lett 157:133-44
|
|
Shao, Z M; Nguyen, M; Barsky, S H (2000) Human breast carcinoma desmoplasia is PDGF initiated. Oncogene 19:4337-45
|
|
Lee, M C; Alpaugh, M L; Nguyen, M et al. (2000) Myoepithelial-specific CD44 shedding is mediated by a putative chymotrypsin-like sheddase. Biochem Biophys Res Commun 279:116-23
|
|
Shao, Z M; Shen, Z Z; Fontana, J A et al. (2000) Genistein's ""ER-dependent and independent"" actions are mediated through ER pathways in ER-positive breast carcinoma cell lines. Anticancer Res 20:2409-16
|
|
Nguyen, M; Lee, M C; Wang, J L et al. (2000) The human myoepithelial cell displays a multifaceted anti-angiogenic phenotype. Oncogene 19:3449-59
|
|
Alpaugh, M L; Lee, M C; Nguyen, M et al. (2000) Myoepithelial-specific CD44 shedding contributes to the anti-invasive and antiangiogenic phenotype of myoepithelial cells. Exp Cell Res 261:150-8
|
Showing the most recent 10 out of 18 publications
